Cortistatin is induced in brain tissue and exerts neuroprotection in a rat model of bacterial meningoencephalitis

Journal of Infectious Diseases

Volumn 204, Issue 10, 2011, Pages 1563-1572

  Chiu, Chien Tsai ^a,b   Wen, Li Li ^c   Pao, Hsin Ping ^d,e   Wang, Jia Yi ^d,e  

^a Graduate Institute of Medical Sciences   (Taiwan)

^b Department of Neurosurgery ^*  (Taiwan)

^c EN CHU KONG HOSPITAL   (Taiwan)

^d NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTISTATIN; DEXAMETHASONE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LACTATE DEHYDROGENASE; MESSENGER RNA; SOMATOSTATIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; BRAIN TISSUE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; DRUG SAFETY; ENZYME ACTIVITY; GENE EXPRESSION; GLIA CELL; IMMUNOMODULATION; IN VIVO STUDY; KLEBSIELLA PNEUMONIAE; LEUKOCYTE; MALE; MENINGOENCEPHALITIS; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; UPREGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CEREBRAL CORTEX; CYTOKINES; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LEUKOCYTOSIS; MALE; MENINGOENCEPHALITIS; NECROSIS; NEUROGENIC INFLAMMATION; NEUROIMMUNOMODULATION; NEUROPEPTIDES; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 80054769189     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir608     Document Type: Article

References (32)

1. Bedford H, de Louvois J, Halket S, Peckham C, Hurley R, Harvey D. Meningitis in infancy in England and Wales: follow up at age 5 years. BMJ 2001; 323:533-6. (Pubitemid 32835570)
2. Merkelbach S, Sittinger H, Schweizer I, Muller M. Cognitive outcome after bacterial meningitis. Acta Neurol Scand 2000; 102:118-23. (Pubitemid 30469506)
3. Grimwood K, Anderson P, Anderson V, Tan L, Nolan T. Twelve year outcomes following bacterial meningitis: further evidence for persisting effects. Arch Dis Child 2000; 83:111-6. (Pubitemid 30670418)
4. Scheld WM, Koedel U, Nathan B, Pfister HW. Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury. J Infect Dis 2002; 186(suppl 2):S225-33. (Pubitemid 35370486)
5. Wen LL, Chiu CT,Huang YN, Chang CF,Wang JY. Rapid glia expression and release of proinflammatory cytokines in experimental Klebsiella pneumoniae meningoencephalitis. Exp Neurol 2007; 205:270-8.
6. Hsu CL, Chang CH, Wong KN, Chen KY, Yu CJ, Yang PC. Management of severe community-acquired septic meningitis in adults: from emergency department to intensive care unit. J Formos Med Assoc 2009; 108:112-8.
7. Lee PY, Chang WN, Lu CH, et al. Clinical features and in vitro antimicrobial susceptibilities of community-acquired Klebsiella pneumoniae meningitis in Taiwan. J Antimicrob Chemother 2003; 51:957-62.
8. Chang WN, Lu CH, Wu JJ, Lei CB, Huang CR. Community-acquired spontaneous Klebsiella pneumoniae meningitis in adult cirrhotic patients with and without diabetes. Eur J ClinMicrobiol InfectDis 2003; 22:271-3. (Pubitemid 36578917)
9. Tang LM, Chen ST, Hsu WC, Chen CM. Klebsiella meningitis in Taiwan: an overview. Epidemiol Infect 1997; 119:135-42.
10. de Lecea L, Criado JR, Prospero-Garcia O, et al. A cortical neuropeptide with neuronal depressant and sleep-modulating properties. Nature 1996; 381:242-5. (Pubitemid 26148671)
11. de Lecea L. Cortistatindfunctions in the central nervous system. Mol Cell Endocrinol 2008; 286:88-95.
12. Spier AD, de Lecea L. Cortistatin: A member of the somatostatin neuropeptide family with distinct physiological functions. Brain Res Brain Res Rev 2000; 33:228-41.
13. Dalm VA, van Hagen PM, van Koetsveld PM, et al. Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells. Am J Physiol Endocrinol Metab 2003; 285:E344-53. (Pubitemid 36899708)
14. Dalm VA, van Hagen PM, van Koetsveld PM, et al. Cortistatin rather than somatostatin as a potential endogenous ligand for somatostatin receptors in the human immune system. J Clin Endocrinol Metab 2003; 88:270-6. (Pubitemid 36115177)
15. Gonzalez-Rey E, Chorny A, Del Moral RG, Varela N, Delgado M. Therapeutic effect of cortistatin on experimental arthritis by downregulating inflammatory and Th1 responses. Ann Rheum Dis 2007; 66:582-8. (Pubitemid 46707125)
16. Gonzalez-Rey E, Varela N, Sheibanie AF, Chorny A, Ganea D,DelgadoM. Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease. Proc Natl Acad Sci U S A 2006; 103:4228-33.
17. Gonzalez-Rey E, Chorny A, Robledo G, Delgado M. Cortistatin, a new antiinflammatory peptide with therapeutic effect on lethal endotoxemia. J Exp Med 2006; 203:563-71.
18. Gonzalez-Rey E, Delgado M. Cortistatin as a potential multistep therapeutic agent for inflammatory disorders. Drug News Perspect 2006; 19:393-9. (Pubitemid 44662167)
19. Broglio F, Arvat E, Benso A, et al. Endocrine activities of cortistatin-14 and its interaction with GHRH and ghrelin in humans. J Clin Endocrinol Metab 2002; 87:3783-90. (Pubitemid 34879528)
20. Broglio F, Koetsveld Pv P, Benso A, et al. Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans. J Clin Endocrinol Metab 2002; 87:4829-32. (Pubitemid 35247084)
21. Huang YN, Wu CH, Lin TC, Wang JY. Methamphetamine induces heme oxygenase-1 expression in cortical neurons and glia to prevent its toxicity. Toxicol Appl Pharmacol 2009; 240:315-26.
22. Wang JY, Shum AY, Chao CC, Kuo JS. Production of macrophage inflammatory protein-2 following hypoxia/reoxygenation in glial cells. Glia 2000; 32:155-64.
23. Hoffmann O, Keilwerth N, Bille MB, et al. Triptans reduce the inflammatory response in bacterial meningitis. J Cereb Blood Flow Metab 2002; 22:988-96. (Pubitemid 34831605)
24. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25:402-8. (Pubitemid 34164012)
25. Koh JY, Choi DW. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J Neurosci Methods 1987; 20:83-90. (Pubitemid 17062742)
26. Wang H, Shimoji M, Yu SW, Dawson TM, Dawson VL. Apoptosis inducing factor and PARP-mediated injury in the MPTP mouse model of Parkinson's disease. Ann N Y Acad Sci 2003; 991:132-9. (Pubitemid 36793809)
27. Wang JY, Shum AY, Ho YJ. Oxidative neurotoxicity in rat cerebral cortex neurons: synergistic effects of H2O2 and NO on apoptosis involving activation of p38 mitogen-activated protein kinase and caspase-3. J Neurosci Res 2003; 72:508-19. (Pubitemid 36523425)
28. Nau R, Bruck W. Neuronal injury in bacterial meningitis: mechanisms and implications for therapy. Trends Neurosci 2002; 25:38-45. (Pubitemid 34093784)
29. Peltola H, Roine I, Fernandez J, et al. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: A prospective, randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2007; 45:1277-86. (Pubitemid 351411900)
30. de Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002; 347:1549-56. (Pubitemid 35315835)
31. Spreer A, Gerber J, Hanssen M, et al. Dexamethasone increases hippocampal neuronal apoptosis in a rabbit model of Escherichia coli meningitis. Pediatr Res 2006; 60:210-5. (Pubitemid 44297595)
32. Leib SL, Heimgartner C, Bifrare YD, Loeffler JM, Taauber MG. Dexamethasone aggravates hippocampal apoptosis and learning deficiency in pneumococcal meningitis in infant rats. Pediatr Res 2003; 54:353-7. (Pubitemid 37013197)